What are the appropriate next steps for a patient who has a positive urine test for blood (hematuria)?

Positive Hemoccult Test: Next Steps

If you have a positive hemoccult (fecal occult blood) test, proceed immediately with colonoscopy to evaluate for colorectal pathology—this is the standard of care and takes priority over any other evaluation. 1

Critical First Step: Clarify the Test Type

The term "hemossure" is not a standard medical test name. You need to determine which test was actually performed:

• If this is a stool-based test (hemoccult/fecal occult blood test): Colonoscopy is mandatory to exclude colorectal cancer and other gastrointestinal pathology 1
• If this is a urine dipstick test: Confirm with microscopic urinalysis showing ≥3 RBCs per high-power field before any further workup 1, 2, 3

---

If This Is Urine Hematuria: Complete Diagnostic Algorithm

Step 1: Confirm True Hematuria (Do Not Skip This)

Order microscopic urinalysis on a properly collected clean-catch midstream specimen immediately. 1, 2

• Dipstick testing has only 65–99% specificity and produces frequent false positives from myoglobin, hemoglobin, menstrual blood, or other contaminants 1, 2
• True hematuria requires ≥3 red blood cells per high-power field (RBC/HPF) on microscopy 1, 3, 4
• If microscopy shows <3 RBC/HPF, document as normal and stop the workup 1

Step 2: Risk Stratification (If ≥3 RBC/HPF Confirmed)

High-risk features that mandate immediate full urologic evaluation (cystoscopy + CT urography): 1, 4, 5

• Age ≥35–40 years (men) or ≥50–60 years (women)
• Smoking history >30 pack-years
• Any prior episode of gross (visible) hematuria, even if self-limited
• Occupational exposure to benzenes, aromatic amines, or industrial chemicals/dyes
• Irritative voiding symptoms (urgency, frequency, dysuria) without documented infection
• Degree of hematuria >25 RBC/HPF

If ANY high-risk feature is present, proceed directly to Step 3. 1, 4

Step 3: Complete Urologic Evaluation for High-Risk Patients

A. Upper Tract Imaging 1, 4

• Multiphasic CT urography is the gold standard (96% sensitivity, 99% specificity for urothelial malignancy) 1
• Must include unenhanced, nephrographic, and excretory phases to evaluate kidneys, ureters, and bladder 1
• Alternative if CT contraindicated: MR urography or renal ultrasound with retrograde pyelography 1

B. Lower Tract Evaluation 1, 6, 4

• Flexible cystoscopy is mandatory for all patients ≥40 years with microscopic hematuria or any patient with gross hematuria 1, 4
• Bladder cancer accounts for 30–40% of gross hematuria and 2.6–4% of microscopic hematuria cases 1, 6
• Imaging alone cannot exclude bladder cancer—direct visualization is required 1

C. Additional Laboratory Tests 1, 4

• Serum creatinine and estimated GFR to assess renal function 1
• Spot urine protein-to-creatinine ratio (>0.5 g/g suggests glomerular disease) 1
• Urine culture before antibiotics if infection suspected 1, 4
• Voided urine cytology in high-risk patients (age >60, smoking >30 pack-years, occupational exposures) 1

Step 4: Distinguish Glomerular vs. Urologic Source

Glomerular indicators (require nephrology referral IN ADDITION to urologic workup): 1, 4

• 80% dysmorphic RBCs on urinary sediment

• Red blood cell casts (pathognomonic for glomerular disease)
• Protein-to-creatinine ratio >0.5 g/g
• Elevated serum creatinine or declining eGFR
• Tea-colored or cola-colored urine
• Concurrent hypertension

Even with glomerular features, complete the full urologic evaluation—malignancy can coexist with renal disease. 1

---

Critical Pitfalls to Avoid

• Never proceed with imaging or cystoscopy based on dipstick alone—microscopic confirmation is mandatory 1, 2, 3
• Never dismiss hematuria in patients >35 years—age alone justifies full evaluation 1, 4
• Never attribute hematuria to anticoagulation/antiplatelet therapy—these medications unmask underlying pathology but do not cause hematuria 1, 4
• Never ignore gross hematuria, even if self-limited—it carries a 30–40% malignancy risk 1, 6
• Never delay evaluation while treating a UTI in patients >35 years—infection does not exclude malignancy 1

---

Follow-Up Protocol (If Initial Workup Negative)

• Repeat urinalysis at 6,12,24, and 36 months with blood pressure monitoring 7, 1
• After two consecutive negative annual urinalyses, further testing is unnecessary 7, 1
• Immediate re-evaluation required if: gross hematuria develops, marked increase in microscopic hematuria, new urologic symptoms, or development of hypertension/proteinuria 7, 1